Proteins > Fructose-1,6-bisphosphatase 1
Page last updated: 2024-08-07 12:55:48
Fructose-1,6-bisphosphatase 1
A fructose-1,6-bisphosphatase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P09467]
Synonyms
FBPase 1;
EC 3.1.3.11;
D-fructose-1,6-bisphosphate 1-phosphohydrolase 1;
Liver FBPase
Research
Bioassay Publications (20)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 6 (30.00) | 2.80 |
Compounds (23)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
mb 05032 | Homo sapiens (human) | EC50 | 0.0160 | 1 | 1 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
aica ribonucleotide | Homo sapiens (human) | ED50 | 250.0000 | 1 | 1 |
mb 05032 | Homo sapiens (human) | Activity | 0.0160 | 1 | 1 |
[no title available]Journal of medicinal chemistry, , 07-14, Volume: 65, Issue:13, 2022
Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes.European journal of medicinal chemistry, , Oct-01, Volume: 203, 2020
Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction.Journal of medicinal chemistry, , 06-11, Volume: 63, Issue:11, 2020
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.Journal of natural products, , 05-22, Volume: 83, Issue:5, 2020
Discovery of Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes.European journal of medicinal chemistry, , Oct-01, Volume: 203, 2020
Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.European journal of medicinal chemistry, , Dec-15, Volume: 184, 2019
Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.Bioorganic & medicinal chemistry, , Mar-15, Volume: 22, Issue:6, 2014
Designing inhibitors against fructose 1,6-bisphosphatase: exploring natural products for novel inhibitor scaffolds.European journal of medicinal chemistry, , Volume: 45, Issue:4, 2010
Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 20, Issue:2, 2010
Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.Journal of medicinal chemistry, , May-14, Volume: 52, Issue:9, 2009
Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines.Bioorganic & medicinal chemistry letters, , Jan-08, Volume: 11, Issue:1, 2001
Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.Bioorganic & medicinal chemistry, , Mar-15, Volume: 22, Issue:6, 2014
Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.Bioorganic & medicinal chemistry, , 09-15, Volume: 28, Issue:18, 2020
Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.European journal of medicinal chemistry, , Dec-15, Volume: 184, 2019
Discovery of Journal of medicinal chemistry, , 09-24, Volume: 63, Issue:18, 2020
Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase.Journal of medicinal chemistry, , Jan-13, Volume: 54, Issue:1, 2011
Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.Journal of medicinal chemistry, , Jan-14, Volume: 53, Issue:1, 2010
Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors.Bioorganic & medicinal chemistry letters, , Oct-15, Volume: 19, Issue:20, 2009
A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase.Bioorganic & medicinal chemistry, , Jun-01, Volume: 17, Issue:11, 2009
Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.Journal of medicinal chemistry, , Jul-24, Volume: 51, Issue:14, 2008
Enables
This protein enables 7 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
AMP binding | molecular function | Binding to AMP, adenosine monophosphate. [GOC:go_curators] |
fructose 1,6-bisphosphate 1-phosphatase activity | molecular function | Catalysis of the reaction: D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate. [EC:3.1.3.11] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
metal ion binding | molecular function | Binding to a metal ion. [GOC:ai] |
monosaccharide binding | molecular function | Binding to a monosaccharide. Monosaccharides are the simplest carbohydrates; they are polyhydroxy aldehydes H[CH(OH)]nC(=O)H or polyhydroxy ketones H[CHOH]nC(=O)[CHOH]mH with three or more carbon atoms. They form the constitutional repeating units of oligo- and polysaccharides. [GOC:jid] |
RNA polymerase II-specific DNA-binding transcription factor binding | molecular function | Binding to a sequence-specific DNA binding RNA polymerase II transcription factor, any of the factors that interact selectively and non-covalently with a specific DNA sequence in order to modulate transcription. [GOC:dph, GOC:vw] |
Located In
This protein is located in 4 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
extracellular exosome | cellular component | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894] |
Active In
This protein is active in 2 target(s):
Target | Category | Definition |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
Involved In
This protein is involved in 20 target(s):
Target | Category | Definition |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
fructose 6-phosphate metabolic process | biological process | The chemical reactions and pathways involving fructose 6-phosphate, also known as F6P. The D-enantiomer is an important intermediate in glycolysis, gluconeogenesis, and fructose metabolism. [ISBN:0198506732] |
gluconeogenesis | biological process | The formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. [MetaCyc:GLUCONEO-PWY] |
regulation of gluconeogenesis | biological process | Any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. [GOC:go_curators] |
dephosphorylation | biological process | The process of removing one or more phosphoric (ester or anhydride) residues from a molecule. [ISBN:0198506732] |
negative regulation of cell growth | biological process | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. [GOC:go_curators] |
response to nutrient levels | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. [GOC:mah] |
cellular response to insulin stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. [GOC:mah, ISBN:0198506732] |
negative regulation of glycolytic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of glycolysis. [GOC:go_curators] |
negative regulation of Ras protein signal transduction | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of Ras protein signal transduction. [GOC:bf] |
cellular response to magnesium ion | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. [GOC:mah] |
cellular response to cAMP | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. [GOC:mah] |
cellular response to xenobiotic stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organism exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:krc, GOC:mah] |
cellular hyperosmotic salinity response | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment. [GOC:mah] |
cellular hypotonic salinity response | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment. [GOC:mah] |
cellular response to raffinose | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a raffinose stimulus. [GOC:al] |
cellular response to phorbol 13-acetate 12-myristate | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus. [GO_REF:0000071, GOC:TermGenie, PMID:2200903] |
fructose 1,6-bisphosphate metabolic process | biological process | The chemical reactions and pathways involving fructose 1,6-bisphosphate, also known as FBP. The D enantiomer is a metabolic intermediate in glycolysis and gluconeogenesis. [ISBN:0198506732] |
fructose metabolic process | biological process | The chemical reactions and pathways involving fructose, the ketohexose arabino-2-hexulose. Fructose exists in a open chain form or as a ring compound. D-fructose is the sweetest of the sugars and is found free in a large number of fruits and honey. [ISBN:0198506732] |
sucrose biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of sucrose, the disaccharide fructofuranosyl-glucopyranoside. [GOC:go_curators] |